I. Kathmann
AuthID: R-006-W8H
1
TITLE: The EGFR TK inhibitor gefitinib (iressa), but not erlotinib (tarceva), is a substrate for BCRP: Impact of cellular folate status on biological activity
AUTHORS: Lemos, C; Kathmann, I; Hoebe, EK; Jansen, G; Peters, GJ;
PUBLISHED: 2006, SOURCE: 4th International Symposium on Targeted Anticancer Therapies in ANNALS OF ONCOLOGY, VOLUME: 17
AUTHORS: Lemos, C; Kathmann, I; Hoebe, EK; Jansen, G; Peters, GJ;
PUBLISHED: 2006, SOURCE: 4th International Symposium on Targeted Anticancer Therapies in ANNALS OF ONCOLOGY, VOLUME: 17
INDEXED IN: 
WOS
WOS